Multi-modal Medical Images for Extraocular Muscle Fibrosis Assessment
Comprehensive Evaluation of Extraocular Muscle Fibrosis in Thyroid Eye Disease With Multi-modal Medical Images
1 other identifier
observational
58
1 country
1
Brief Summary
The purpose of this study was to evaluate the elasticity of the extraocular muscles in different stages of thyroid eye disease and to examine the correlation of MRI parameters (native T1 value and ECV) and elasticity for the assessment of extraocular muscles fibrosis in the thyroid eye disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 28, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedJuly 9, 2025
June 1, 2025
5.4 years
June 28, 2025
June 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MRI parameters (native T1 value and ECV) and elasticity of EOMs in the TED.
Consecutive patients with moderate-to-severe TED were retrospectively enrolled from Tianjin Eye Hospital between 2020 and 2024. All patients underwent MR with T1 mapping and RTE. The patients were categorized into either the active or inactive TED
Study Arms (2)
patients group
Consecutive patients with moderate-to-severe TED
control group
The sex-matched control group comprised healthy individuals and patients with orbital symptoms but normal findings on orbital MRI
Interventions
The patients were categorized into either the active or inactive TED group based on the Clinical Activity Score
Eligibility Criteria
Study Design and Participants Consecutive patients (n=40) with moderate-to-severe TED were retrospectively enrolled from Tianjin Eye Hospital between 2020 and 2024. All patients underwent MR with T1 mapping and RTE. The patients were categorized into either the active or inactive TED group based on the Clinical Activity Score (CAS). The sex-matched control group (n=18) comprised healthy individuals and patients with orbital symptoms but normal findings on orbital MRI. All participants underwent a comprehensive ophthalmic examination, including slit-lamp biomicroscopy, Hertel exophthalmometry and intraocular pressure. A blood sample was obtained on the day of MR scanning to measure hematocrit.
You may qualify if:
- Consecutive patients with moderate-to-severe TED were retrospectively enrolled from Tianjin Eye Hospital between 2020 and 2024.
You may not qualify if:
- Participants who reported any of the following were excluded: (1) any ophthalmopathies (e.g., glaucoma, diabetic retinopathy and optic nerve disorders); (2) patients with dysthyroid optic neuropathy (DON).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tianjin Eye Hospital
Tianjin, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 4 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2025
First Posted
July 9, 2025
Study Start
January 1, 2020
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
July 9, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share